Arrowhead Pharmaceuticals, Inc. (FRA:HDP1)

Arrowhead Pharmaceuticals Statistics

Total Valuation

FRA:HDP1 has a market cap or net worth of EUR 8.17 billion. The enterprise value is 8.06 billion.

Market Cap	8.17B
Enterprise Value	8.06B

Important Dates

The next estimated earnings date is Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	140.01M
Shares Outstanding	n/a
Shares Change (YoY)	+11.67%
Shares Change (QoQ)	-0.84%
Owned by Insiders (%)	3.74%
Owned by Institutions (%)	73.11%
Float	121.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.56
PB Ratio	19.04
P/TBV Ratio	20.88
P/FCF Ratio	61.10
P/OCF Ratio	53.39
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 68.96, with an EV/FCF ratio of 60.25.

EV / Earnings	-5,795.09
EV / Sales	11.54
EV / EBITDA	68.96
EV / EBIT	97.32
EV / FCF	60.25

Financial Position

The company has a current ratio of 4.86, with a Debt / Equity ratio of 1.48.

Current Ratio	4.86
Quick Ratio	4.73
Debt / Equity	1.48
Debt / EBITDA	5.36
Debt / FCF	4.74
Interest Coverage	1.10

Financial Efficiency

Return on equity (ROE) is 8.67% and return on invested capital (ROIC) is 17.11%.

Return on Equity (ROE)	8.67%
Return on Assets (ROA)	4.87%
Return on Invested Capital (ROIC)	17.11%
Return on Capital Employed (ROCE)	8.27%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	994,288
Profits Per Employee	-1,955
Employee Count	711
Asset Turnover	0.66
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:HDP1 has paid 18.26 million in taxes.

Income Tax	18.26M
Effective Tax Rate	41.56%

Stock Price Statistics

The stock price has increased by +206.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+206.27%
50-Day Moving Average	52.91
200-Day Moving Average	28.10
Relative Strength Index (RSI)	56.85
Average Volume (20 Days)	219

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.03

Income Statement

In the last 12 months, FRA:HDP1 had revenue of EUR 706.94 million and -1.39 million in losses. Loss per share was -0.01.

Revenue	706.94M
Gross Profit	706.94M
Operating Income	83.82M
Pretax Income	43.92M
Net Income	-1.39M
EBITDA	104.21M
EBIT	83.82M
Loss Per Share	-0.01

Balance Sheet

The company has 781.96 million in cash and 634.10 million in debt, with a net cash position of 147.86 million.

Cash & Cash Equivalents	781.96M
Total Debt	634.10M
Net Cash	147.86M
Net Cash Per Share	n/a
Equity (Book Value)	429.06M
Book Value Per Share	2.93
Working Capital	643.62M

Cash Flow

In the last 12 months, operating cash flow was 153.03 million and capital expenditures -19.32 million, giving a free cash flow of 133.71 million.

Operating Cash Flow	153.03M
Capital Expenditures	-19.32M
Free Cash Flow	133.71M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 11.86% and -0.20%.

Gross Margin	100.00%
Operating Margin	11.86%
Pretax Margin	6.21%
Profit Margin	-0.20%
EBITDA Margin	14.74%
EBIT Margin	11.86%
FCF Margin	18.91%

Dividends & Yields

FRA:HDP1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.67%
Shareholder Yield	-11.67%
Earnings Yield	-0.02%
FCF Yield	1.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 17, 2011. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 17, 2011
Split Type	Reverse
Split Ratio	0.1

Scores

FRA:HDP1 has an Altman Z-Score of 1.51 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.51
Piotroski F-Score	5